Header Logo

PAUL W WALKER

TitleAssociate Professor
InstitutionMD Anderson
DepartmentPalliative Care & Rehabilitation Medicine
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Walker PR. Immunotherapy: remember the host. Transl Lung Cancer Res. 2023 Dec 26; 12(12):2366-2369. PMID: 38205215; PMCID: PMC10775002.
      Citations:    
    2. Naqash AR, McCallen JD, Mi E, Iivanainen S, Marie MA, Gramenitskaya D, Clark J, Koivunen JP, Macherla S, Jonnalagadda S, Polsani S, Jiwani RA, Hafiz M, Muzaffar M, Brunetti L, Stroud CRG, Walker PR, Wang K, Chung Y, Ruppin E, Lee SH, Yang LV, Pinato DJ, Lee JS, Cortellini A. Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer. J Immunother Cancer. 2023 10; 11(10). PMID: 37852738; PMCID: PMC10603340.
      Citations: 4     Fields:    Translation:HumansCells
    3. Walker PR. Induction treatment in operable non-small cell lung cancer: the immune oncology era unfolds. J Thorac Dis. 2023 Jul 31; 15(7):3533-3537. PMID: 37559643; PMCID: PMC10407505.
      Citations:    
    4. Pasli M, Kannaiyan R, Namireddy P, Walker P, Muzaffar M. Impact of Race on Outcomes of Advanced Stage Non-Small Cell Lung Cancer Patients Receiving Immunotherapy. Curr Oncol. 2023 04 18; 30(4):4208-4221. PMID: 37185434; PMCID: PMC10136836.
      Citations:    Fields:    Translation:Humans
    5. Son C, Moey MYY, Walker PR, Naqash AR, Peach MS, Ju AW. Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy. Front Oncol. 2022; 12:1025455. PMID: 36698405; PMCID: PMC9868592.
      Citations:    
    6. Marie MA, McCallen JD, Hamedi ZS, Naqash AR, Hoffman A, Atwell D, Amara S, Muzaffar M, Walker PR, Yang LV. Case Report: Peripheral blood T cells and inflammatory molecules in lung cancer patients with immune checkpoint inhibitor-induced thyroid dysfunction: Case studies and literature review. Front Oncol. 2022; 12:1023545. PMID: 36568170; PMCID: PMC9768626.
      Citations:    
    7. Walker P. Liquid Biopsy and the Translational Bridge from the TIME to the Clinic. Cells. 2022 10 03; 11(19). PMID: 36231076; PMCID: PMC9563580.
      Citations:    
    8. Woody S, Hegde A, Arastu H, Peach MS, Sharma N, Walker P, Ju AW. Survival Is Worse in Patients Completing Immunotherapy Prior to SBRT/SRS Compared to Those Receiving It Concurrently or After. Front Oncol. 2022; 12:785350. PMID: 35692764; PMCID: PMC9184512.
      Citations:    
    9. Rich P, Mitchell RB, Schaefer E, Walker PR, Dubay JW, Boyd J, Oubre D, Page R, Khalil M, Sinha S, Boniol S, Halawani H, Santos ES, Brenner W, Orsini JM, Pauli E, Goldberg J, Veatch A, Haut M, Ghabach B, Bidyasar S, Quejada M, Khan W, Huang K, Traylor L, Akerley W. Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer. J Immunother Cancer. 2021 10; 9(10). PMID: 34706885; PMCID: PMC8552188.
      Citations:    
    10. McCallen JD, Naqash AR, Marie MA, Atwell DC, Muzaffar M, Sharma N, Amara S, Liles D, Walker PR, Yang LV. Peripheral blood interleukin 6, interleukin 10, and T lymphocyte levels are associated with checkpoint inhibitor induced pneumonitis: a case report. Acta Oncol. 2021 06; 60(6):813-817. PMID: 33939588.
      Citations:    Fields:    
    11. Shankar B, Zhang J, Naqash AR, Forde PM, Feliciano JL, Marrone KA, Ettinger DS, Hann CL, Brahmer JR, Ricciuti B, Owen D, Toi Y, Walker P, Otterson GA, Patel SH, Sugawara S, Naidoo J. Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer. JAMA Oncol. 2020 12 01; 6(12):1952-1956. PMID: 33119034; PMCID: PMC7596677.
      Citations:    
    12. Moey MYY, Tomdio AN, McCallen JD, Vaughan LM, O'Brien K, Naqash AR, Cherry C, Walker PR, Carabello BA. Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting. JACC CardioOncol. 2020 Sep; 2(3):491-502. PMID: 34396256; PMCID: PMC8352337.
      Citations:    
    13. Naqash AR, Ricciuti B, Owen DH, Florou V, Toi Y, Cherry C, Hafiz M, De Giglio A, Muzaffar M, Patel SH, Sugawara S, Burkart J, Park W, Chiari R, Sugisaka J, Otterson GA, de Lima Lopes G, Walker PR. Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort. Cancer Immunol Immunother. 2020 07; 69(7):1189. PMID: 32347358; PMCID: PMC11027581.
      Citations:    Fields:    
    14. Sehgal K, Bulumulle A, Brody H, Gill RR, Macherla S, Qilleri A, McDonald DC, Cherry CR, Shea M, Huberman MS, VanderLaan PA, Weiss GJ, Walker PR, Costa DB, Rangachari D. Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer. Clin Lung Cancer. 2021 05; 22(3):e379-e389. PMID: 32653295; PMCID: PMC7273162.
      Citations: 2     Fields:    
    15. Naqash AR, Ricciuti B, Owen DH, Florou V, Toi Y, Cherry C, Hafiz M, De Giglio A, Muzaffar M, Patel SH, Sugawara S, Burkart J, Park W, Chiari R, Sugisaka J, Otterson GA, de Lima Lopes G, Walker PR. Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort. Cancer Immunol Immunother. 2020 Jul; 69(7):1177-1187. PMID: 32140762; PMCID: PMC11027623.
      Citations: 12     Fields:    Translation:Humans
    16. Bowling M, Arastu H, Edwards V, Jackson L, Thurston S, Reese J, Mellert H, Pestano G, Walker P. Longitudinal monitoring for the emergence of epidermal growth factor C797S resistance mutations in non-small cell lung cancer using blood-based droplet digital PCR. Cancer Drug Resist. 2019; 2(3):912-916. PMID: 35582570; PMCID: PMC8992510.
      Citations:    
    17. Stowe H, Ogake S, Sharma S, Kelly S, McDonald M, Stanley K, Walker P, Arastu H, Granadillo CA, Bowling M, Ju A. Improved respiratory motion tracking through a novel fiducial marker placement guidance system during electromagnetic navigational bronchoscopy (ENB). Radiat Oncol. 2019 Jul 11; 14(1):124. PMID: 31296231; PMCID: PMC6625013.
      Citations:    
    18. Allard M, Marinari E, Corlazzoli F, Gustave R, Kreutzfeldt M, Koka A, Momjian S, Lobrinus A, Merkler D, Vargas MI, Walker PR, Migliorini D, Dutoit V, Grandjean Hallez N, Widmer V, Philippin G, Blazek N, Wasem J, Hottinger A, Patrikidou A, Dietrich PY. Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients. Neuro Oncol. 2019 07 11; 21(7):923-933. PMID: 30753611; PMCID: PMC6620642.
      Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
    19. Naqash AR, Appah E, Yang LV, Muzaffar M, Marie MA, Mccallen JD, Macherla S, Liles D, Walker PR. Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition. J Immunother Cancer. 2019 07 05; 7(1):169. PMID: 31277704; PMCID: PMC6612131.
      Citations: 7     Fields:    Translation:Humans
    20. Hafiz M, Sundaram S, Naqash AR, Speicher J, Sutton A, Walker P, Talaat N. A Rare Case of Squamous Cell Carcinoma of the Esophagus in a Patient With Goltz Syndrome. ACG Case Rep J. 2019 Mar; 6(3):1-4. PMID: 31620495; PMCID: PMC6658022.
      Citations:    
    21. Cykert S, Eng E, Walker P, Manning MA, Robertson LB, Arya R, Jones NS, Heron DE. A system-based intervention to reduce Black-White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers. Cancer Med. 2019 03; 8(3):1095-1102. PMID: 30714689; PMCID: PMC6434214.
      Citations:    
    22. Pierson C, Grinchak T, Sokolovic C, Holland B, Parent T, Bowling M, Arastu H, Walker P, Ju A. Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy. Radiat Oncol. 2018 Feb 27; 13(1):34. PMID: 29486779; PMCID: PMC5830069.
      Citations:    
    23. Naqash AR, Stroud CRG, Butt MU, Dy GK, Hegde A, Muzaffar M, Yang LV, Hafiz M, Cherry CR, Walker PR. Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database. Acta Oncol. 2018 06; 57(6):867-872. PMID: 29241410; PMCID: PMC5990460.
      Citations: 11     Fields:    Translation:Humans
    24. Stroud CR, Hegde A, Cherry C, Naqash AR, Sharma N, Addepalli S, Cherukuri S, Parent T, Hardin J, Walker P. Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade. J Oncol Pharm Pract. 2019 Apr; 25(3):551-557. PMID: 29207939.
      Citations:    
    25. Naqash AR, Yang LV, Sanderlin EJ, Atwell DC, Walker PR. Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report. Acta Oncol. 2018 05; 57(5):705-708. PMID: 29171332.
      Citations: 8     Fields:    Translation:Humans
    26. Biswas T, Efird JT, Prasad S, Jindal C, Walker PR. The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer. Oncotarget. 2017 Dec 22; 8(68):112712-112719. PMID: 29348858; PMCID: PMC5762543.
      Citations: 13     Fields:    
    27. Migliorini D, Ranzanici G, Marinari E, Lobrinus JA, Momjian S, Costello J, Walker PR, Okada H, Herold-Mende C, Dietrich PY, Dutoit V, Widmer V, Weinschenk T. Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma. Oncoimmunology. 2018; 7(2):e1391972. PMID: 29308320; PMCID: PMC5749651.
      Citations: 11     
    28. Hui D, Frisbee-Hume S, Wilson A, Dibaj SS, Nguyen T, De La Cruz M, Walker P, Zhukovsky DS, Delgado-Guay M, Vidal M, Epner D, Reddy A, Tanco K, Williams J, Hall S, Liu D, Hess K, Amin S, Breitbart W, Bruera E. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial. JAMA. 2017 09 19; 318(11):1047-1056. PMID: 28975307; PMCID: PMC5661867.
      Citations: 41     Fields:    Translation:Humans
    29. Kalman NS, Weiss E, Walker PR, Rosenman JG. Local Radiotherapy Intensification for Locally Advanced Non-small-cell Lung Cancer - A Call to Arms. Clin Lung Cancer. 2018 01; 19(1):17-26. PMID: 28712978.
      Citations: 5     Fields:    Translation:Humans
    30. Naqash AR, Stroud G, Collichio FA, Muzaffar M, Sharma N, Walker P. Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumab. Acta Oncol. 2017 10; 56(10):1327-1330. PMID: 28481677.
      Citations:    
    31. Karvinen KH, Vallance J, Walker PR. Newly diagnosed lung cancer patients' preferences for and beliefs about physical activity prior to chemotherapy. Psychol Health Med. 2016 Jul; 21(5):593-600. PMID: 26813963.
      Citations: 4     Fields:    Translation:Humans
    32. Biswas T, Walker P, Podder T, Efird JT. Effect of Race and Insurance on the Outcome of Stage I Non-small Cell Lung Cancer. Anticancer Res. 2015 Jul; 35(7):4243-9. PMID: 26124385.
      Citations:    
    33. Hui D, dos Santos R, Reddy S, Nascimento MS, Zhukovsky DS, Paiva CE, Dalal S, Costa ED, Walker P, Scapulatempo HH, Dev R, Crovador CS, De La Cruz M, Bruera E. Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study. Palliat Med. 2015 Oct; 29(9):826-33. PMID: 25881622.
      Citations: 12     Fields:    Translation:Humans
    34. Bowling MR, Kohan MW, Walker P, Efird J, Ben Or S. The effect of general anesthesia versus intravenous sedation on diagnostic yield and success in electromagnetic navigation bronchoscopy. J Bronchology Interv Pulmonol. 2015 Jan; 22(1):5-13. PMID: 25590477.
      Citations:    
    35. Cykert S, Walker PR, Edwards LJ, McGuire FR, Dilworth-Anderson P. Weighing projections of physical decline in lung cancer surgery decisions. Am J Med Sci. 2015 Jan; 349(1):61-6. PMID: 25285513.
      Citations: 1     Fields:    Translation:Humans
    36. Biswas T, Walker P, Podder T, Rosenman J, Efird J. Important prognostic factors for lung cancer in tobacco predominant Eastern North Carolina: study based on a single cancer registry. Lung Cancer. 2014 May; 84(2):116-20. PMID: 24602393.
      Citations:    
    37. Esposito D, Raedeke TD, Vick J, Walker PR, Karvinen KH. Effect of an exercise training intervention with resistance bands on blood cell counts during chemotherapy for lung cancer: a pilot randomized controlled trial. Springerplus. 2014; 3:15. PMID: 24683529; PMCID: PMC3967733.
      Citations: 7     
    38. Dalton AF, Bunton AJ, Cykert S, Corbie-Smith G, Dilworth-Anderson P, McGuire FR, Monroe MH, Walker P, Edwards LJ. Patient characteristics associated with favorable perceptions of patient-provider communication in early-stage lung cancer treatment. J Health Commun. 2014; 19(5):532-44. PMID: 24359327.
      Citations:    
    39. Hopkinson N, Wallis C, Higgins B, Gaduzo S, Sherrington R, Keilty S, Stern M, Britton J, Bush A, Moxham J, Sylvester K, Griffiths V, Sutherland T, Crossingham I, Raju R, Spencer C, Safavi S, Deegan P, Seymour J, Hickman K, Hughes J, Wieboldt J, Shaheen F, Peedell C, Mackenzie N, Nicholl D, Jolley C, Crooks G, Dow C, Deveson P, Bintcliffe O, Gray B, Kumar S, Haney S, Docherty M, Thomas A, Chua F, Dwarakanath A, Summers G, Prowse K, Lytton S, Ong YE, Graves J, Banerjee T, English P, Leonard A, Brunet M, Chaudhry N, Ketchell RI, Cummings N, Lebus J, Sharp C, Meadows C, Harle A, Stewart T, Parry D, Templeton-Wright S, Moore-Gillon J, Stratford- Martin J, Saini S, Matusiewicz S, Merritt S, Dowson L, Satkunam K, Hodgson L, Suh ES, Durrington H, Browne E, Walters N, Steier J, Barry S, Griffiths M, Hart N, Nikolic M, Berry M, Thomas A, Miller J, McNicholl D, Marsden P, Warwick G, Barr L, Adeboyeku D, Mohd Noh MS, Griffiths P, Davies L, Quint J, Lyall R, Shribman J, Collins A, Goldman J, Bloch S, Gill A, Man W, Christopher A, Yasso R, Rajhan A, Shrikrishna D, Moore C, Absalom G, Booton R, Fowler RW, Mackinlay C, Sapey E, Lock S, Walker P, Jha A, Satia I, Bradley B, Mustfa N, Haqqee R, Thomas M, Patel A, Redington A, Pillai A, Keaney N, Fowler S, Lowe L, Brennan A, Morrison D, Murray C, Hankinson J, Dutta P, Maddocks M, Pengo M, Curtis K, Rafferty G, Hutchinson J, Whitfield R, Turner S, Breen R, Naveed SU, Goode C, Esterbrook G, Ahmed L, Walker W, Ford D, Connett G, Davidson P, Elston W, Stanton A, Morgan D, Myerson J, Maxwell D, Harrris A, Parmar S, Houghton C, Winter R, Puthucheary Z, Thomson F, Sturney S, Harvey J, Haslam PL, Patel I, Jennings D, Range S, Mallia-Milanes B, Collett A, Tate P, Russell R, Feary J, O'Driscoll R, Eaden J, Round J, Sharkey E, Montgomery M, Vaughan S, Scheele K, Lithgow A, Partridge S, Chavasse R, Restrick L, Agrawal S, Abdallah S, Lacy-Colson A, Adams N, Mitchell S, Haja Mydin H, Ward A, Denniston S, Steel M, Ghosh D, Connellan S, Rigge L, Williams R, Grove A, Anwar S, Dobson L, Hosker H, Stableforth D, Greening N, Howell T, Casswell G, Davies S, Tunnicliffe G, Mitchelmore P, Phitidis E, Robinson L, Bafadhel M, Robinson G, Boland A, Lipman M, Bourke S, Kaul S, Cowie C, Forrest I, Starren E, Burke H, Furness J, Bhowmik A, Everett C, Seaton D, Holmes S, Doe S, Parker S, Graham A, Paterson I, Maqsood U, Ohri C, Iles P, Kemp S, Iftikhar A, Carlin C, Fletcher T, Emerson P, Beasley V, Ramsay M, Buttery R, Mungall S, Crooks S, Ridyard J, Ross D, Guadagno A, Holden E, Coutts I, Cullen K, O'Connor S, Barker J, Sloper K, Watson J, Smith P, Anderson P, Brown L, Nyman C, Milburn H, Clive A, Serlin M, Bolton C, Fuld J, Powell H, Dayer M, Woolhouse I, Georgiadi A, Leonard H, Dodd J, Campbell I, Ruiz G, Zurek A, Paton JY, Malin A, Wood F, Hynes G, Connell D, Spencer D, Brown S, Smith D, Cooper D, O'Kane C, Hicks A, Creagh-Brown B, Lordan J, Nickol A, Primhak R, Fleming L, Powrie D, Brown J, Zoumot Z, Elkin S, Szram J, Scaffardi A, Marshall R, Macdonald I, Lightbody D, Farmer R, Wheatley I, Radnan P, Lane I, Booth A, Tilbrook S, Capstick T, Hewitt L, McHugh M, Nelson C, Wilson P, Padmanaban V, White J, Davison J, O'Callaghan U, Hodson M, Edwards J, Campbell C, Ward S, Wooler E, Ringrose E, Bridges D, Long A, Parkes M, Clarke S, Allen B, Connelly C, Forster G, Hoadley J, Martin K, Barnham K, Khan K, Munday M, Edwards C, O'Hara D, Turner S, Pieri-Davies S, Ford K, Daniels T, Wright J, Towns R, Fern K, Butcher J, Burgin K, Winter B, Freeman D, Olive S, Gray L, Pye K, Roots D, Cox N, Davies CA, Wicker J, Hilton K, Lloyd J, MacBean V, Wood M, Kowal J, Downs J, Ryan H, Guyatt F, Nicoll D, Lyons E, Narasimhan D, Rodman A, Walmsley S, Newey A, Buxton M, Dewar M, Cooper A, Reilly J, Lloyd J, Macmillan AB, Olley A, Voase N, Martin S, McCarvill I, Christensen A, Agate R, Heslop K, Timlett A, Hailes K, Davey C, Pawulska B, Lane A, Ioakim S, Hough A, Treharne J, Jones H, Winter-Burke A, Miller L, Connolly B, et al. Children must be protected from the tobacco industry's marketing tactics. BMJ. 2013 Dec 09; 347:f7358. PMID: 24324220.
      Citations:    Fields:    Translation:Humans
    40. Gay HA, Taylor QQ, Kiriyama F, Dieck GT, Jenkins T, Walker P, Allison RR, Ubezio P. Modeling of non-small cell lung cancer volume changes during CT-based image guided radiotherapy: patterns observed and clinical implications. Comput Math Methods Med. 2013; 2013:637181. PMID: 24260040; PMCID: PMC3821906.
      Citations:    
    41. Zhang J, Gay HA, Russo S, Parent T, Aljumaily R, Walker PR. Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer. Lung Cancer. 2014 Jan; 83(1):67-72. PMID: 24246506.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    42. Walker P, Diggelmann H, Ropp BY, Hanson JA, Hoffman HT. Suction modulation for the laryngeal microdebrider. Laryngoscope. 2013 Jun; 123(6):1496-9. PMID: 23553177.
      Citations:    
    43. Karvinen KH, McGourty S, Parent T, Walker PR. Physical activity promotion among oncology nurses. Cancer Nurs. 2012 May-Jun; 35(3):E41-8. PMID: 21946904.
      Citations: 15     Fields:    Translation:Humans
    44. Hui D, Kilgore K, Nguyen L, Hall S, Fajardo J, Cox-Miller TP, Palla SL, Rhondali W, Kang JH, Kim SH, Del Fabbro E, Zhukovsky DS, Reddy S, Elsayem A, Dalal S, Dev R, Walker P, Yennu S, Reddy A, Bruera E. The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist. 2011; 16(11):1642-8. PMID: 21976316; PMCID: PMC3233300.
      Citations: 29     Fields:    Translation:Humans
    45. Cykert S, Dilworth-Anderson P, Monroe MH, Walker P, McGuire FR, Corbie-Smith G, Edwards LJ, Bunton AJ. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA. 2010 Jun 16; 303(23):2368-76. PMID: 20551407; PMCID: PMC4152904.
      Citations:    
    46. Yennurajalingam S, Dev R, Walker PW, Reddy SK, Bruera E. Challenges associated with spinal opioid therapy for pain in patients with advanced cancer: a report of three cases. J Pain Symptom Manage. 2010 May; 39(5):930-5. PMID: 20471553.
      Citations: 3     Fields:    Translation:Humans
    47. Quan W, Knupp C, Quan F, Walker P. Pulse infusion interleukin-2 with famotidine and cyclophosphamide has activity in previously treated metastatic melanoma. Cancer Biother Radiopharm. 2010 Apr; 25(2):179-83. PMID: 20423231.
      Citations:    
    48. Reddy S, Hui D, El Osta B, de la Cruz M, Walker P, Palmer JL, Bruera E. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med. 2010 Jan; 13(1):33-8. PMID: 19824814; PMCID: PMC2939847.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    49. Quan WD, Walker PR, Picton M, Quan FM, King LA, Tyre C, Liles DK. High-dose intensity pulse interleukin-2 with famotidine has activity in metastatic melanoma. Cancer Biother Radiopharm. 2008 Oct; 23(5):641-6. PMID: 18999936.
      Citations: 1     Fields:    Translation:HumansCells
    50. Walker PW, Palla S, Pei BL, Kaur G, Zhang K, Hanohano J, Munsell M, Bruera E. Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med. 2008 Oct; 11(8):1103-8. PMID: 18980450; PMCID: PMC2982711.
      Citations: 22     Fields:    Translation:Humans
    51. Walker PW, Bruera E, Boohene J. Managing high dose sufentanil in a suffering patient. J Pain Symptom Manage. 2008 Jul; 36(1):e1-4. PMID: 18538537.
      Citations:    Fields:    Translation:Humans
    52. Quan WD, Quan FM, King LA, Walker PR. Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer. Cancer Biother Radiopharm. 2008 Feb; 23(1):108-13. PMID: 18298334.
      Citations: 3     Fields:    Translation:Humans
    53. Del Fabbro E, Reddy SG, Walker P, Bruera E. Palliative sedation: when the family and consulting service see no alternative. J Palliat Med. 2007 Apr; 10(2):488-92. PMID: 17472523.
      Citations: 5     Fields:    Translation:Humans
    54. Quan WD, Milligan KS, Quan FM, Cuenca RE, Khan N, Liles DK, Walker PR. Continuous infusion interleukin-2 and intravenous famotidine in metastatic melanoma. Cancer Biother Radiopharm. 2006 Dec; 21(6):607-12. PMID: 17257076.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    55. Rubio-Godoy V, Schrenzel J, Walker PR, Romero PJ, Valmori D, Speiser DE, Dietrich PY, Le Gal FA, Widmer VM, Dutoit V. Tissue homing and persistence of defined antigen-specific CD8+ tumor-reactive T-cell clones in long-term melanoma survivors. J Invest Dermatol. 2007 Mar; 127(3):622-9. PMID: 17039243.
      Citations: 4     Fields:    Translation:HumansCells
    56. Quan WD, Walker PR, Quan FM, Ramirez M, Elsamaloty HM, Ghai V, Vinogradov M, Liles DK. Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2. Cancer Biother Radiopharm. 2006 Oct; 21(5):437-42. PMID: 17105418.
      Citations:    Fields:    Translation:HumansCells
    57. Quan WD, Vinogradov M, Quan FM, Khan N, Liles DK, Walker PR. Continuous infusion interleukin-2 and famotidine in metastatic kidney cancer. Cancer Biother Radiopharm. 2006 Oct; 21(5):515-9. PMID: 17105423.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    58. Walker P, Neuhauser MN, Tam VH, Willey JS, Palmer JL, Bruera E, Prince RA. Subcutaneous administration of cefepime. J Pain Symptom Manage. 2005 Aug; 30(2):170-4. PMID: 16125032.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    59. Strasser F, Walker P, Bruera E. Palliative pain management: when both pain and suffering hurt. J Palliat Care. 2005; 21(2):69-79. PMID: 16114805.
      Citations: 13     Fields:    Translation:Humans
    60. Elsayem A, Swint K, Fisch MJ, Palmer JL, Reddy S, Walker P, Zhukovsky D, Knight P, Bruera E. Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol. 2004 May 15; 22(10):2008-14. PMID: 15143094.
      Citations: 61     Fields:    Translation:Humans
    61. Vaena DA, Walker P, Pennington K, Stephens A, Stender MJ, Yiannoutsos CT, Young C, Stoner C, Cripe LD, Hoosier Oncology Group. Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study. Leuk Res. 2004 Jan; 28(1):49-52. PMID: 14630080.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    62. Vigano A, Romano F, Neumann C, Hanson J, Quan HK, Walker P, Roemer-B?cuwe C. Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration. J Pain Symptom Manage. 2003 Sep; 26(3):843-8. PMID: 12967733.
      Citations: 4     Fields:    Translation:Humans
    63. Skeel RT, Huang J, Manola J, Wilding G, Dreicer R, Walker P, Muggia F, Crawford ED, Dutcher JP, Loehrer PJ. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893). Cancer Invest. 2003; 21(1):41-6. PMID: 12643008.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    64. Walker P. Management of pressure ulcers. Oncology (Williston Park). 2001 Nov; 15(11):1499-508, 1511; discussion1511,1515-6. PMID: 11758876.
      Citations:    Fields:    Translation:Humans
    65. Walker P, Nordell C, Neumann CM, Bruera E. Impact of the Edmonton Labeled Visual Information System on physician recall of metastatic cancer patient histories. a randomized controlled trial. J Pain Symptom Manage. 2001 Jan; 21(1):4-11. PMID: 11223309.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    66. Doyle J, Walker P, Bruera E. Nebulized scopolamine. J Pain Symptom Manage. 2000 May; 19(5):327-8. PMID: 10928852.
      Citations:    Fields:    Translation:Humans
    67. Gagnon B, Bielech M, Watanabe S, Walker P, Hanson J, Bruera E. The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Support Care Cancer. 1999 Jul; 7(4):265-70. PMID: 10423053.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    68. Walker P, Watanabe S, Bruera E. Baclofen, a treatment for chronic hiccup. J Pain Symptom Manage. 1998 Aug; 16(2):125-32. PMID: 9737104.
      Citations: 12     Fields:    Translation:Humans
    69. Lawlor PG, Watanabe S, Walker P, Bruera E. Re: Memorial Delirium Assessment Scale and commentary. J Pain Symptom Manage. 1998 Feb; 15(2):73-5. PMID: 9494304.
      Citations:    Fields:    Translation:Humans
    70. Pereira J, Mancini I, Walker P. The role of bisphosphonates in malignant bone pain: a review. J Palliat Care. 1998; 14(2):25-36. PMID: 9686493.
      Citations: 1     Fields:    Translation:Humans
    71. Walker P, Watanabe S, Lawlor P, Hanson J, Pereira J, Bruera E. Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity. Ann Oncol. 1997 Sep; 8(9):915-6. PMID: 9358945.
      Citations: 6     Fields:    Translation:Humans
    72. Lawlor P, Walker P, Bruera E, Mitchell S. Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence. J Pain Symptom Manage. 1997 Jun; 13(6):356-61. PMID: 9204657.
      Citations: 13     Fields:    Translation:Humans
    73. Walker P, Watanabe S, Taube A. The Edmonton Staging System. J Pain Symptom Manage. 1996 Nov; 12(5):269. PMID: 8942119.
      Citations: 1     Fields:    Translation:Humans
    74. Walker P, Watanabe S, Lawlor P, Bruera E. Subcutaneous clodronate. Lancet. 1996 Aug 03; 348(9023):345-6. PMID: 8709722.
      Citations: 1     Fields:    Translation:Humans
    75. Preface. Hematology/Oncology Clinics of North America. 16.
    WALKER's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (279)
    Explore
    _
    Co-Authors (14)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _